Cargando…
Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review
Background: Sirolimus, a mammalian target of rapamycin inhibitor, has been widely used in pediatric patients, but the safety of sirolimus in pediatric patients has not been well determined. Objective: The objective of this study was to systematically evaluate prospective studies reporting the safety...
Autores principales: | Zhang, Zixin, Li, Yanan, Zhang, Guangyue, Yang, Kaiying, Qiu, Tong, Zhou, Jiangyuan, Gong, Xue, Ji, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497617/ https://www.ncbi.nlm.nih.gov/pubmed/36138604 http://dx.doi.org/10.3390/children9091295 |
Ejemplares similares
-
Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study
por: Qiu, Tong, et al.
Publicado: (2023) -
Sirolimus in the treatment of kaposiform lymphangiomatosis
por: Zhou, Jiangyuan, et al.
Publicado: (2021) -
Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma
por: Yang, Kaiying, et al.
Publicado: (2023) -
Case Report: Bilateral symmetrical primary kaposiform hemangioendothelioma of the femur
por: Qiu, Tong, et al.
Publicado: (2022) -
Integrated nontargeted and targeted metabolomics analyses amino acids metabolism in infantile hemangioma
por: Yang, Kaiying, et al.
Publicado: (2023)